Literature DB >> 3089941

Impact on peritonsillar infections and microflora of phenoxymethylpenicillin alone versus phenoxymethylpenicillin in combination with metronidazole.

K Tunér, C E Nord.   

Abstract

In a double-blind study, 20 patients with peritonsillar abscesses were treated with 2 g phenoxymethylpenicillin b.i.d. for ten days together with needle aspiration, incision and daily drainage, and 20 patients were treated with 2 g phenoxymethylpenicillin b.i.d. and 0.8 g metronidazole b.i.d. for ten days together with needle aspiration, incision and daily drainage. Group A beta-hemolytic streptococci were isolated from pus in 20 of the patients with peritonsillar abscesses, in five of these together with indigenous oropharyngeal aerobic and anaerobic microorganisms. Pure anaerobic bacteria were found in nine abscesses, together with indigenous aerobic microorganisms in eight, and together with group A, C and G streptococci in five. In one patient heavily colonized with beta-lactamase-producing Staphylococcus aureus, Haemophilus parainfluenzae and Bacteroides, group A beta-streptococci failed to be eradicated. In the penicillin group, nine of 18 patients harboured beta-lactamase producing Bacteroides strains in the tonsils on the day of admission. On the third and tenth days of treatment all patients harboured beta-lactamase producing Bacteroides strains in the tonsils, while in the penicillin + metronidazole group, only one out of 17 patients still harboured beta-lactamase producing Bacteroides strains. None of the patients harboured beta-lactamase producing fusobacteria on the day of admission. In the penicillin group, however, beta-lactamase producing fusobacteria were recovered from three patients on the tenth day of treatment. No beta-lactamase producing fusobacteria were recovered from the penicillin + metronidazole group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089941     DOI: 10.1007/bf01643477

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  30 in total

1.  Immediate tonsillectomy for the treatment of peritonsillar abscess.

Authors:  J W Templer; L D Holinger; R P Wood; N T Tra; G B DeBlanc
Journal:  Am J Surg       Date:  1977-11       Impact factor: 2.565

2.  Streptococcal anti-desoxyribonuclease B: microtechnique determination.

Authors:  J Nelson; E M Ayoub; L W Wannamaker
Journal:  J Lab Clin Med       Date:  1968-05

3.  Novel beta-lactamase from Branhamella catarrhalis.

Authors:  A B Hoi-Dang; C Brive-Le Bouguenec; M Barthelemy; R Labia
Journal:  Ann Microbiol (Paris)       Date:  1978-10

4.  Peritonsillar abscess: tonsil antibiotic levels in patients treated by acute abscess surgery.

Authors:  R H Maisel
Journal:  Laryngoscope       Date:  1982-01       Impact factor: 3.325

5.  Possible role of the anaerobe in tonsillitis.

Authors:  S Reilly; P Timmis; A G Beeden; A T Willis
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

6.  Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus.

Authors:  P R Murray; J E Rosenblatt
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

7.  In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.

Authors:  I Brook; G Pazzaglia; J C Coolbaugh; R I Walker
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

8.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.

Authors:  S Maruyama; H Yoshioka; K Fujita; M Takimoto; Y Satake
Journal:  Am J Dis Child       Date:  1979-11

9.  Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis.

Authors:  K Tunér; C E Nord
Journal:  Ann Otol Rhinol Laryngol       Date:  1985 May-Jun       Impact factor: 1.547

10.  Quantitative measurement of beta lactamase in tonsils of children with recurrent tonsillitis.

Authors:  I Brook; P Yocum
Journal:  Acta Otolaryngol       Date:  1984 Nov-Dec       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.